Table 1.

Patient characteristics

Patient CharacteristicsNo. of Patients (%)
Age, yr; median, 71.5 yr (range, 38–97 yr)
 <501/42 (2.4)
 51–604/42 (9.5)
 61–7015/42 (35.7)
 71–8013/42 (31.0)
 81–906/42 (14.3)
 >903/42 (7.1)
Men29/42 (69.0)
Self-identified race
 Hispanic24/42 (57.1)
 White3/42 (7.1)
 Black5/42 (11.9)
 Other2/42 (4.8)
 Unknown8/42 (19.0)
Comorbidities
 HTNa30/41 (73.2)
 DMa17/41 (41.5)
 CAD or CVAa13/41 (31.7)
 Obesity (BMI>30)b10/32 (31.3)
 Immunosuppressedc2/40 (5.0)
 CKDd8/28 (28.5)
Time spent in hospital, d; median, 7.7 d (range, 0–40 d)
 Deceased upon arrival6/42 (14.3)
 <11/42 (2.4)
 1–38/42 (19.0)
 3–52/42 (4.8)
 5–107/42 (16.7)
 10–153/42 (7.1)
 >1515/42 (35.7)
  • BMI, body mass index.

  • a Comorbidities were unknown in one patient.

  • b BMI was not available in ten patients.

  • c Of the two immunosuppressed patients, one had amyotrophic lateral sclerosis on adalimumab, and one was a liver transplant recipient.

  • d Baseline creatinine was missing in 14 patients.